Cargando…

Mediastinal germ cell tumors: cohort of patients with this rare entity

BACKGROUND: Extragonadal germ cell tumors are infrequent and represent between 1–10% of all mediastinal tumors. It presents differences to those of gonadal location in terms of clinical presentation, behavior and prognosis which is poor even with treatment. METHODS: Retrospective and descriptive coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Florencia Belén, Patané, Ana Karina, Rosales, Adolfo, Rosenberg, Moisés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794349/
https://www.ncbi.nlm.nih.gov/pubmed/35118299
http://dx.doi.org/10.21037/med-20-55
_version_ 1784640806656671744
author Basile, Florencia Belén
Patané, Ana Karina
Rosales, Adolfo
Rosenberg, Moisés
author_facet Basile, Florencia Belén
Patané, Ana Karina
Rosales, Adolfo
Rosenberg, Moisés
author_sort Basile, Florencia Belén
collection PubMed
description BACKGROUND: Extragonadal germ cell tumors are infrequent and represent between 1–10% of all mediastinal tumors. It presents differences to those of gonadal location in terms of clinical presentation, behavior and prognosis which is poor even with treatment. METHODS: Retrospective and descriptive cohort study on 16 patients with diagnosis of mediastinal germ cell tumor surgically treated at Maria Ferrer Respiratory Rehabilitation Hospital and Alexander Fleming Specialized Medical Institute. RESULTS: Nine men and 7 women were analyzed over a period of 10 years. The median age was significantly lower among men (22 vs. 38 years, P<0.01). The most common initial symptom was pain in 43.75%. Chest tomography was the diagnostic method used in 13 patients (81.25%). Tumor marker levels were raised in 7 patients (43.75%), and decreased after surgery. All women had a mature teratoma, however, no statistically significant difference was found at the histological distribution by gender (P=0.336). The median tumor size was 9.50 centimeters. The most frequent surgical approach was sternotomy. No woman in the series received treatment before or after surgery, while 88.90% of men received neoadjuvant treatment for invasion or intimate contact with neighboring structures (P=0.001). Chemotherapy was indicated in 33.30% of the male population due to relapse. The median follow-up was 36 months (range, 1–95 months). No statistically significant differences were observed in the median follow-up (P=0.950), the percentage of relapses (P=0.091) and overall survival by gender (P=0.335). Overall survival was 75%. CONCLUSIONS: Tumors were predominantly primary and not seminomatous. Multimodal treatment was a useful tool to improve the chances of resection and overall survival. There was a percentage of women higher than the published literature, teratomas predominated in them, and surgery was the only necessary treatment.
format Online
Article
Text
id pubmed-8794349
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87943492022-02-02 Mediastinal germ cell tumors: cohort of patients with this rare entity Basile, Florencia Belén Patané, Ana Karina Rosales, Adolfo Rosenberg, Moisés Mediastinum Original Article BACKGROUND: Extragonadal germ cell tumors are infrequent and represent between 1–10% of all mediastinal tumors. It presents differences to those of gonadal location in terms of clinical presentation, behavior and prognosis which is poor even with treatment. METHODS: Retrospective and descriptive cohort study on 16 patients with diagnosis of mediastinal germ cell tumor surgically treated at Maria Ferrer Respiratory Rehabilitation Hospital and Alexander Fleming Specialized Medical Institute. RESULTS: Nine men and 7 women were analyzed over a period of 10 years. The median age was significantly lower among men (22 vs. 38 years, P<0.01). The most common initial symptom was pain in 43.75%. Chest tomography was the diagnostic method used in 13 patients (81.25%). Tumor marker levels were raised in 7 patients (43.75%), and decreased after surgery. All women had a mature teratoma, however, no statistically significant difference was found at the histological distribution by gender (P=0.336). The median tumor size was 9.50 centimeters. The most frequent surgical approach was sternotomy. No woman in the series received treatment before or after surgery, while 88.90% of men received neoadjuvant treatment for invasion or intimate contact with neighboring structures (P=0.001). Chemotherapy was indicated in 33.30% of the male population due to relapse. The median follow-up was 36 months (range, 1–95 months). No statistically significant differences were observed in the median follow-up (P=0.950), the percentage of relapses (P=0.091) and overall survival by gender (P=0.335). Overall survival was 75%. CONCLUSIONS: Tumors were predominantly primary and not seminomatous. Multimodal treatment was a useful tool to improve the chances of resection and overall survival. There was a percentage of women higher than the published literature, teratomas predominated in them, and surgery was the only necessary treatment. AME Publishing Company 2020-12-30 /pmc/articles/PMC8794349/ /pubmed/35118299 http://dx.doi.org/10.21037/med-20-55 Text en 2020 Mediastinum. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Basile, Florencia Belén
Patané, Ana Karina
Rosales, Adolfo
Rosenberg, Moisés
Mediastinal germ cell tumors: cohort of patients with this rare entity
title Mediastinal germ cell tumors: cohort of patients with this rare entity
title_full Mediastinal germ cell tumors: cohort of patients with this rare entity
title_fullStr Mediastinal germ cell tumors: cohort of patients with this rare entity
title_full_unstemmed Mediastinal germ cell tumors: cohort of patients with this rare entity
title_short Mediastinal germ cell tumors: cohort of patients with this rare entity
title_sort mediastinal germ cell tumors: cohort of patients with this rare entity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794349/
https://www.ncbi.nlm.nih.gov/pubmed/35118299
http://dx.doi.org/10.21037/med-20-55
work_keys_str_mv AT basileflorenciabelen mediastinalgermcelltumorscohortofpatientswiththisrareentity
AT pataneanakarina mediastinalgermcelltumorscohortofpatientswiththisrareentity
AT rosalesadolfo mediastinalgermcelltumorscohortofpatientswiththisrareentity
AT rosenbergmoises mediastinalgermcelltumorscohortofpatientswiththisrareentity